Public COA audit
Triple Agonist
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 92
- Confidence
- 88%
- Panels
- 3/7
- Purity (printed)
- 99.8%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- CR-3XAG15-2603-1
- Identity method
- FTIR (USP <197A>)
- Sample date
- 2026-04-02
- Issue date
- 2026-04-05
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
FTIR sample spectrum confirms the presence of Triple Agonist with addition of excipient(s)/fillers
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.8%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Not on this COA
Bioburden / microbial limits testing.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
24.4 EU/vial (limit: 40 EU/vial)
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High HPLC purity achieved
99.8% purity by HPLC (USP <621>) exceeds specification of ≥98%, which is normal for research-grade peptides
Identity confirmed by FTIR
FTIR spectrum confirms Triple Agonist with excipients/fillers present, consistent with formulated peptide product
Batch/lot number present
Lot CR-3XAG15-2603-1 clearly documented
Dates documented and consistent
Date tested: 2026-04-02, Issue date: 2026-04-05 (3-day turnaround). Endotoxin test dated 2026-04-08/2026-04-10. All dates are on or before 2026-07-28 and are valid.
Testing lab identified
BTLabs, West Palm Beach, FL with contact information and website provided
Multiple analytical panels performed
Identity (FTIR), purity (HPLC), potency (HPLC), and endotoxin testing completed. Heavy metals, microbial, sterility, and residual solvent panels not performed (common for research peptides)
Professional formatting with supporting data
Report includes FTIR spectrum, HPLC chromatogram, triplicate measurements, QR code, signatures, and detailed methodology references
Potency within specification
HPLC potency assay shows 15.1-15.5 mg (100.5-103.5% of labeled 15 mg), within 90-110% specification
Limited safety panels
Heavy metals, microbial contamination, and sterility testing not performed. Document explicitly states it does not provide information on particulate matter or microbial contamination (except endotoxin)
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.